Mannkind (MNKD) Net Margin (2010 - 2026)

Mannkind (MNKD) posted quarterly Net Margin of 18.43% for Q1 2026, down 3522.0% year-over-year from 0.54% in Q1 2025, and down 29.38% quarter-over-quarter from 14.25% in Q4 2025.

Mannkind (MNKD) Net Margin (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has reported Net Margin for 14 consecutive years, with 18.43% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Margin fell 3522.0% year-over-year to 18.43%; the TTM figure through Mar 2026 stood at 6.64% (down 1675.0% YoY), while the FY2025 annual figure was 1.68%, down 798.0% from the prior year.
  • Net Margin eased to 18.43% in Q1 2026 per MNKD's latest filing, from 14.25% in the prior quarter.
  • Across five years, Net Margin topped out at 16.79% in Q1 2025 and bottomed at 216.79% in Q1 2022.
  • Historically, Net Margin has averaged 26.8% across 5 years, with a median of 2.78% in 2024.
  • Annual changes were most pronounced in 2022 — Net Margin slumped 14272 bps — and 2023, when it soared 19268 bps.
  • Mannkind's Net Margin stood at 49.77% in 2022, then jumped by 105 bps to 2.41% in 2023, then jumped by 301 bps to 9.66% in 2024, then sank by 247 bps to 14.25% in 2025, then fell by 29 bps to 18.43% in 2026.
  • Business Quant data shows MNKD's Net Margin at 18.43% in Q1 2026, 14.25% in Q4 2025, and 9.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Mannkind 1.19 Bn 1.08 Bn 94.97 Mn -17.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.40%
Mar 31, 2026 -18.43%
Dec 31, 2025 -14.25%
Sep 30, 2025 9.72%
Jun 30, 2025 0.84%
Mar 31, 2025 16.79%
Dec 31, 2024 9.66%
Sep 30, 2024 16.48%
Jun 30, 2024 -2.78%
Mar 31, 2024 16.04%
Dec 31, 2023 2.41%
Sep 30, 2023 6.98%
Jun 30, 2023 -10.83%
Mar 31, 2023 -24.11%
Dec 31, 2022 -49.77%
Sep 30, 2022 -43.97%
Jun 30, 2022 -153.61%
Mar 31, 2022 -216.79%
Dec 31, 2021 -224.22%
Sep 30, 2021 -19.93%